Prenetics Global Limited

PRE
$12.88 (1.33%) 12:00 AM 20/11/25
#64 in Bitcoin Treasuries

Market

Market Overview

Market Cap
Shares Outstanding
50-Day Moving Average
200-Day Moving Average
Average Volume (20 Days)
Beta (5Y)
  • Chart chart view
  • Table table view
  • Price
  • Market Cap MCap
  • Shares
Start Date
start date
to
End Date
start date

About

Company Overview

Prenetics Global Limited, an investment holding company, operates as a diagnostics and genetic testing company. Its products include CircleDNA, a consumer genetic testing product; and Circle HealthPod, a rapid detection health monitoring system that allows users to take COVID-19 tests at point-of-care or at home utilizing the nucleic acid amplification test. The company's products also comprise ColoClear, a non-invasive FIT-DNA colorectal cancer screening test; Circle SnapShot, an off-the-shelf at-home blood test; Circle Medical, a diagnostic testing product; and Circle One and F1x/Fem. Prenetics Global Limited was founded in 2014 and is headquartered in Quarry Bay, Hong Kong.

Stock Exchange NASDAQ
IPO Date 2021-07-16
Number of Employees 285
Headquarters Quarry Bay, HK

Key Executives

News

Press Releases

FAQ

The next earnings report date for Prenetics Global Limited (PRE) is scheduled for April 29, 2026. Stay up to date with PRE’s financial results and key announcements by visiting our Earnings Tracker or by subscribing to earnings alerts. Here we also provide PRE earnings call summaries and transcripts.

As of November 14, 2025, Prenetics Global Limited holds approximately 390 BTC as part of its corporate Bitcoin treasury strategy. For more comprehensive insights, you can track PRE 's Bitcoin holdings on our Bitcoin Treasuries page.

The current stock price of Prenetics Global Limited (PRE) is $12.88 as of 12:00 AM 20/11/25. For live stock updates and company rankings, view our Bitcoin mining stocks by market cap table.

The latest news for Prenetics Global Limited (PRE) includes Cantor Fitzgerald Reiterates Overweight Rating on Prenetics with Price Target of $31 Following Strong IM8 Growth published on November 14, 2025. For more details and ongoing updates, visit the PRE news section.